Skip to content

KLRS KLRS Earnings yield

Earnings yield at other companies

Eli Lilly logo
Eli LillyLLY
3.1%+1.6pp
Merck & Co. logo
Merck & Co.MRK
3%-4.7pp
Amgen logo
AmgenAMGN
4.1%+0.6pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
5.4%-1.1pp
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
-25.3%-6.7pp
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-15.8%-0.7pp

Other financials

Income statement

See full
Operating income-$11.8M-14.3%
Net income-$10.9M-6.5%
EPS (diluted)-$0.46+81.7%

Balance sheet

See full
Cash & equivalents$34.4M-65.9%
Total debt$1.4M
Total equity$68.6M+7.3%
Total assets$109.8M+6.5%

Cash flow

See full
Operating cash flow-$11.6M-55.6%
CapEx$17.0K
Free cash flow-$7.1M

Valuation

See full
Market cap$96.83M+136%
Enterprise value$63.82M

Returns & leverage

See full
Return on equity-66.6%
Debt / equity
Current ratio12.2×-2.1×

Where this comes from

Calculated from KLRS’s reported figures.

Based on trailing twelve months.

The official record: KLRS’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about KLRS's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KLRS's earnings yield?
KLRS (KLRS) reported earnings yield of -33.3% in Q1 2026.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.